277 related articles for article (PubMed ID: 32628980)
1. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months.
Oldham V; Mumford B; Lee D; Jones J; Das G
Diabetes Res Clin Pract; 2020 Aug; 166():108281. PubMed ID: 32628980
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control.
Quirós C; Giménez M; Ríos P; Careaga M; Roca D; Vidal M; Conget I
Diabet Med; 2016 Oct; 33(10):1422-6. PubMed ID: 26870914
[TBL] [Abstract][Full Text] [Related]
3. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and associations of psychological distress in young adults with Type 1 diabetes.
Hislop AL; Fegan PG; Schlaeppi MJ; Duck M; Yeap BB
Diabet Med; 2008 Jan; 25(1):91-6. PubMed ID: 18199136
[TBL] [Abstract][Full Text] [Related]
6. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Association Between Diabetes Distress and Self-Management Behaviors.
Khan A; Choudhary P
J Diabetes Sci Technol; 2018 Nov; 12(6):1116-1124. PubMed ID: 30101610
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
10. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
[TBL] [Abstract][Full Text] [Related]
12. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
[TBL] [Abstract][Full Text] [Related]
14. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
15. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
16. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
[TBL] [Abstract][Full Text] [Related]
17. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
[TBL] [Abstract][Full Text] [Related]
18. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
Grant P; Dworakowska D; DeZoysa N; Barnes D
Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
[TBL] [Abstract][Full Text] [Related]
19. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
Dicembrini I; Mannucci E; Monami M; Pala L
Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
